143 related articles for article (PubMed ID: 15816892)
41. Long-term health-related quality of life and walking capacity of lung recipients with and without bronchiolitis obliterans syndrome.
Gerbase MW; Soccal PM; Spiliopoulos A; Nicod LP; Rochat T
J Heart Lung Transplant; 2008 Aug; 27(8):898-904. PubMed ID: 18656804
[TBL] [Abstract][Full Text] [Related]
42. Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities?
Jackson CH; Sharples LD; McNeil K; Stewart S; Wallwork J
J Heart Lung Transplant; 2002 Jun; 21(6):658-66. PubMed ID: 12057699
[TBL] [Abstract][Full Text] [Related]
43. Determinants of quality of life after lung transplant: an Italian collaborative study.
Ricotti S; Vitulo P; Petrucci L; Oggionni T; Klersy C;
Monaldi Arch Chest Dis; 2006 Mar; 65(1):5-12. PubMed ID: 16700187
[TBL] [Abstract][Full Text] [Related]
44. Bronchiolitis obliterans syndrome (BOS) following heart-lung transplantation.
Tamm M; Sharples L; Higenbottam T; Stewart S; Wallwork J
Transpl Int; 1996; 9 Suppl 1():S299-302. PubMed ID: 8959850
[TBL] [Abstract][Full Text] [Related]
45. Association of soluble HLA-G with acute rejection episodes and early development of bronchiolitis obliterans in lung transplantation.
White SR; Floreth T; Liao C; Bhorade SM
PLoS One; 2014; 9(7):e103643. PubMed ID: 25068264
[TBL] [Abstract][Full Text] [Related]
46. Increased plasma mannose binding lectin levels are associated with bronchiolitis obliterans after lung transplantation.
Budd SJ; Aris RM; Medaiyese AA; Tilley SL; Neuringer IP
Respir Res; 2012 Jul; 13(1):56. PubMed ID: 22762710
[TBL] [Abstract][Full Text] [Related]
47. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
Glanville AR; Aboyoun CL; Havryk A; Plit M; Rainer S; Malouf MA
Am J Respir Crit Care Med; 2008 May; 177(9):1033-40. PubMed ID: 18263803
[TBL] [Abstract][Full Text] [Related]
48. Bronchiolitis obliterans syndrome development in lung transplantation patients.
Parada MT; Alba A; Sepúlveda C
Transplant Proc; 2010; 42(1):331-2. PubMed ID: 20172344
[TBL] [Abstract][Full Text] [Related]
49. The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.
DerHovanessian A; Weigt SS; Palchevskiy V; Shino MY; Sayah DM; Gregson AL; Noble PW; Palmer SM; Fishbein MC; Kubak BM; Ardehali A; Ross DJ; Saggar R; Lynch JP; Elashoff RM; Belperio JA
Am J Transplant; 2016 Feb; 16(2):640-9. PubMed ID: 26461171
[TBL] [Abstract][Full Text] [Related]
50. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
[TBL] [Abstract][Full Text] [Related]
51. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction.
Kaza V; Zhu C; Terada LS; Wang L; Torres F; Bollineni S; Mohanka M; Banga A; Joerns J; Mohanakumar T; Li QZ
Hum Immunol; 2021 Jan; 82(1):25-35. PubMed ID: 33129576
[TBL] [Abstract][Full Text] [Related]
52. Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients.
Finlen Copeland CA; Snyder LD; Zaas DW; Turbyfill WJ; Davis WA; Palmer SM
Am J Respir Crit Care Med; 2010 Sep; 182(6):784-9. PubMed ID: 20508211
[TBL] [Abstract][Full Text] [Related]
53. Blood CD9
Brosseau C; Danger R; Durand M; Durand E; Foureau A; Lacoste P; Tissot A; Roux A; Reynaud-Gaubert M; Kessler R; Mussot S; Dromer C; Brugière O; Mornex JF; Guillemain R; Claustre J; Magnan A; Brouard S;
Am J Transplant; 2019 Nov; 19(11):3162-3175. PubMed ID: 31305014
[TBL] [Abstract][Full Text] [Related]
54. Everolimus in lung transplantation in Chile.
Parada MT; Alba A; Sepúlveda C
Transplant Proc; 2010; 42(1):328-30. PubMed ID: 20172343
[TBL] [Abstract][Full Text] [Related]
55. Cross sectional study of exhaled nitric oxide levels following lung transplantation.
Fisher AJ; Gabbay E; Small T; Doig S; Dark JH; Corris PA
Thorax; 1998 Jun; 53(6):454-8. PubMed ID: 9713443
[TBL] [Abstract][Full Text] [Related]
56. Assessment of mean transit time in the engrafted lung with 133Xe lung ventilation scintigraphy improves diagnosis of bronchiolitis obliterans syndrome in living-donor lobar lung transplant recipients.
Shinya T; Sato S; Kato K; Gobara H; Akaki S; Date H; Kanazawa S
Ann Nucl Med; 2008 Jan; 22(1):31-9. PubMed ID: 18250985
[TBL] [Abstract][Full Text] [Related]
57. Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients.
Nord M; Schubert K; Cassel TN; Andersson O; Riise GC
Transplantation; 2002 Apr; 73(8):1264-9. PubMed ID: 11981419
[TBL] [Abstract][Full Text] [Related]
58. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334
[TBL] [Abstract][Full Text] [Related]
59. Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung.
Riise GC; Williams A; Kjellström C; Schersten H; Andersson BA; Kelly FJ
Eur Respir J; 1998 Jul; 12(1):82-8. PubMed ID: 9701419
[TBL] [Abstract][Full Text] [Related]
60. Graft ischemic time and outcome of lung transplantation: a multicenter analysis.
Thabut G; Mal H; Cerrina J; Dartevelle P; Dromer C; Velly JF; Stern M; Loirat P; Lesèche G; Bertocchi M; Mornex JF; Haloun A; Despins P; Pison C; Blin D; Reynaud-Gaubert M
Am J Respir Crit Care Med; 2005 Apr; 171(7):786-91. PubMed ID: 15665320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
